Full Issue
Editorial
Sarcoidosis Vasculitis and Diffuse Lung Disease: alive and still growing
Abstract 210 | PDF Downloads 114 | DOI https://doi.org/10.36141/svdld.v37i2.10080Page 86
Review
Infection prevention in sarcoidosis: proposal for vaccination and prophylactic therapy
Abstract 429 | PDF Downloads 279 | DOI https://doi.org/10.36141/svdld.v37i2.9599Page 87-98
Original Articles: Clinical Research
The right upper lobe bronchus angle: A tool for differentiating fibrotic and non-fibrotic sarcoidosis
Abstract 262 | PDF Downloads 98 | DOI https://doi.org/10.36141/svdld.v37i2.8965Page 99-103
Sarcoidosis and increased risk of comorbidities and mortality in Sweden
Abstract 276 | PDF Downloads 163 | DOI https://doi.org/10.36141/svdld.v37i2.9142Page 104-135
Treatment of Primary Sjögren’s Syndrome-Related Interstitial Lung Disease: a Retrospective Cohort Study
Abstract 573 | PDF Downloads 390 | DOI https://doi.org/10.36141/svdld.v37i2.8461Page 136-147
A real-world study of the tolerability and dosing of pirfenidone and its effect on survival in idiopathic pulmonary fibrosis
Abstract 293 | PDF Downloads 225 | DOI https://doi.org/10.36141/svdld.v37i2.8718Page 148-157
Predictors of cough-specific and generic quality of life in sarcoidosis patients
Abstract 319 | PDF Downloads 218 | DOI https://doi.org/10.36141/svdld.v37i2.9234Page 158-168
Obstructive sleep apnea in sarcoidosis and impact of CPAP treatment on fatigue
Abstract 448 | PDF Downloads 305 | DOI https://doi.org/10.36141/svdld.v37i2.9169Page 169-178
A unique case of ovarian manifestation of systemic vasculitis that mimics ovarian cancer.
Abstract 364 | PDF Downloads 172 | DOI https://doi.org/10.36141/svdld.v37i2.8181Page 179-183
Long-term outcomes of epoprostenol therapy in sarcoid associated pulmonary hypertensio
Abstract 258 | PDF Downloads 139 | DOI https://doi.org/10.36141/svdld.v37i2.9150Page 184-191
The effect of the walk-bike on quality of life and exercise capacity in patients with idiopathic pulmonary fibrosis: a feasibility study
Abstract 872 | PDF Downloads 614 | DOI https://doi.org/10.36141/svdld.v37i2.9433Page 192-202
Associations between interleukin 18 gene polymorphisms and susceptibility to vasculitis: A meta-analysis
Abstract 261 | PDF Downloads 200 | DOI https://doi.org/10.36141/svdld.v37i2.9399Page 203-211
Role of alveolar collapse in idiopathic pleuroparenchymal fibroelastosis
Abstract 160 | PDF Downloads 109 | DOI https://doi.org/10.36141/svdld.v37i2.9981Page 212-217
Real world experience of response to pirfenidone in patients with idiopathic pulmonary fibrosis: a two centre retrospective study
Abstract 292 | PDF Downloads 176 | DOI https://doi.org/10.36141/svdld.v37i2.8587Page 218-224
Case Series
Non-tuberculous, adenosine deaminase-positive lymphocytic pleural effusion: Consider immunoglobulin G4-related disease
Abstract 277 | PDF Downloads 176 | DOI https://doi.org/10.36141/svdld.v37i2.9098Page 225-230
Rapidly non-IPF progressive fibrosing interstitial lung disease: a phenotype with an IPF-like behavior
Abstract 413 | PDF Downloads 263 | DOI https://doi.org/10.36141/svdld.v37i2.9276Page 231-233
Treatment of newly diagnosed sarcoid-associated pulmonary hypertension with ambrisentan and tadalafil combination therapy
Abstract 379 | PDF Downloads 250 | DOI https://doi.org/10.36141/svdld.v37i2.9343Page 234-238
Letter to Editor
Pulmonary arterial hypertension secondary to Takayasu’s Arteritis: management using a combined medical and interventional approach
Abstract 172 | PDF Downloads 119 | DOI https://doi.org/10.36141/svdld.v37i2.8987Page 239-241
Subcutaneous sarcoidosis: a report of 13 cases and its association with extracutaneous sarcoidosis
Abstract 149 | PDF Downloads 85 | DOI https://doi.org/10.36141/svdld.v37i2.9199Page 242-245